ECGI FDA-Approved Breast Cancer Detection Device S
Post# of 579
Posted On: 11/19/2014 3:39:48 PM
ECGI FDA-Approved Breast Cancer Detection Device Sets Stock for Big Moves Up
(NEW YORK)--Event Cardio Group, Inc.(OTC:ECGI), a medical device company, may continue its run as it closes licensing agreement to deploy product in US and China.
In late Oct. 2014, the Company announced agreement with Life Medical Technologies, Inc. in respect to Life Medical's "BreastCare DTS(TM) device, for exclusive rights in United States, Canada, and Asia.
Breast cancer is a majorly popular subject, and the prospects of $ECGI developing a non-invasive breast cancer detection device could really send this play much higher. Since early fall the stock has been rising, and chart indicates this run may only just be beginning.
ECGI current has no debt or debentures outstanding, which may also prevent any undo dilution to stock on any spikes up.
BreastCare DTS™ is a single-use device used as an adjunct to clinical breast examination and mammography in the detection of breast abnormalities. "DTS" stands for "Differential Temperature Sensor," indicating the ability of the device to compare temperatures in one breast with the other. The BreastCare DTS™ device consists of two-mirror image, lightweight, disposable foam pads with three wafer-thin foil sensors on each pad containing 18 rows of heat-sensitive chemical dots. The device is easy to use, requires no electricity or probes, and is completely non-invasive.
(NEW YORK)--Event Cardio Group, Inc.(OTC:ECGI), a medical device company, may continue its run as it closes licensing agreement to deploy product in US and China.
In late Oct. 2014, the Company announced agreement with Life Medical Technologies, Inc. in respect to Life Medical's "BreastCare DTS(TM) device, for exclusive rights in United States, Canada, and Asia.
Breast cancer is a majorly popular subject, and the prospects of $ECGI developing a non-invasive breast cancer detection device could really send this play much higher. Since early fall the stock has been rising, and chart indicates this run may only just be beginning.
ECGI current has no debt or debentures outstanding, which may also prevent any undo dilution to stock on any spikes up.
BreastCare DTS™ is a single-use device used as an adjunct to clinical breast examination and mammography in the detection of breast abnormalities. "DTS" stands for "Differential Temperature Sensor," indicating the ability of the device to compare temperatures in one breast with the other. The BreastCare DTS™ device consists of two-mirror image, lightweight, disposable foam pads with three wafer-thin foil sensors on each pad containing 18 rows of heat-sensitive chemical dots. The device is easy to use, requires no electricity or probes, and is completely non-invasive.
(0)
(0)Scroll down for more posts ▼